Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Arthritis, Rheumatoid D001172 3 associated lipids
Liver Diseases D008107 31 associated lipids
Occupational Diseases D009784 42 associated lipids
Kidney Diseases D007674 29 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Myocardial Infarction D009203 21 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Souqiyyeh MZ and Shaheen FA Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. 2003 Apr-Jun Saudi J Kidney Dis Transpl pmid:18209438
Zolezzi M Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. 2003 Apr-Jun Saudi J Kidney Dis Transpl pmid:18209437
pmid:18208026
Al-Saran KA and Sabry AA Pregnancy in dialysis patients: a case series. 2008 J Med Case Rep pmid:18205953
Al-Mueilo SH Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. 2005 Apr-Jun Saudi J Kidney Dis Transpl pmid:18202490
Pai AB et al. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study. 2007 Clin Ther pmid:18201586
Wall GC and Pauly RA Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. 2008 Am J Health Syst Pharm pmid:18192261
Hasegawa K et al. [Improvement of urinary d-glucaric acid assay and its application]. 2008 Yakugaku Zasshi pmid:18176065
pmid:18118003
Liu Z et al. Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. 2008 Nucl Med Commun pmid:18094633
Roth S et al. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. 2008 Transl Res pmid:18061126
Franco G et al. Behaviour of urinary D-glucaric acid excretion in surgical patients and anaesthesiology staff acutely exposed to isoflurane and nitrous oxide. 1991 Nov-Dec Med Lav pmid:1803214
pmid:17994454
Wang S et al. Chemical reactions of vitamin C with intravenous-iron formulations. 2008 Nephrol. Dial. Transplant. pmid:17951305
Francis GS and Kanderian A Anemia and heart failure a new pathway? 2007 J. Am. Coll. Cardiol. pmid:17950148
Toblli JE et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. 2007 J. Am. Coll. Cardiol. pmid:17950147
Teschke O et al. Quorum sensing detected by atomic force microscopy imaging of corrals surrounding multicellular arrangement of bacteria. 2008 Microsc. Res. Tech. pmid:17943987
Saluk-Juszczak J et al. Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets. 2008 Nutr Metab Cardiovasc Dis pmid:17933501
Sato K [Drug-induced osteomalacia]. 2007 Clin Calcium pmid:17906405
Olas B et al. D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets. 2008 Cell Biol. Toxicol. pmid:17846905
Malindretos P et al. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. 2007 Am. J. Nephrol. pmid:17804904
Singh J and Gupta KP Induction of apoptosis by calcium D-glucarate in 7,12-dimethyl benz [a] anthracene-exposed mouse skin. 2007 J. Environ. Pathol. Toxicol. Oncol. pmid:17725531
Grzegorzewska AE [Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease]. 2007 Pol. Arch. Med. Wewn. pmid:17722476
Breymann C Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex. 2005 J Med Assoc Thai pmid:17718296
Vindal V et al. GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. 2007 BMC Genomics pmid:17714599
Tryfinopoulou P et al. Diversity of Shewanella population in fish Sparus aurata harvested in the Aegean Sea. 2007 J. Appl. Microbiol. pmid:17714405
Zager RA Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease. 2006 Clin J Am Soc Nephrol pmid:17699373
Bishu K and Agarwal R Acute injury with intravenous iron and concerns regarding long-term safety. 2006 Clin J Am Soc Nephrol pmid:17699372
Singh H et al. Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. 2006 Clin J Am Soc Nephrol pmid:17699248
Thomas J and Martinez A Blood conservation in the critically ill. 2007 Am J Health Syst Pharm pmid:17687066
Shaheen FA et al. Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. 2002 Apr-Jun Saudi J Kidney Dis Transpl pmid:17660651
Reed J et al. The safety of intravenous iron sucrose use in the elderly patient. 2007 Consult Pharm pmid:17658969
Yew WS et al. Evolution of enzymatic activities in the enolase superfamily: L-talarate/galactarate dehydratase from Salmonella typhimurium LT2. 2007 Biochemistry pmid:17649980
Vikrant S Optimum dosage regimen for iron sucrose. 2007 Kidney Int. pmid:17625585
Agarwal R et al. Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. 2007 Kidney Int. pmid:17622274
Auerbach M and Rodgers GM Intravenous iron. 2007 N. Engl. J. Med. pmid:17611217
Herzberg M et al. Hepatic microsomal enzyme induction and its evaluation in a clinical laboratory. 1977 Isr. J. Med. Sci. pmid:17578
pmid:17577885
Breborowicz A et al. Peritoneal effects of intravenous iron sucrose administration in rats. 2007 Transl Res pmid:17543848
Sav T et al. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? 2007 Ren Fail pmid:17497463
Iversen C et al. The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. 2007 BMC Evol. Biol. pmid:17439656
Sane R et al. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. 2007 Pharmacotherapy pmid:17381390
Ranfaing E [Treatments of the martial deficiencies: preparations available in France]. 2006 Nephrol. Ther. pmid:17373280
Beck-da-Silva L et al. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. 2007 J. Card. Fail. pmid:17338998
George P et al. Coronary artery vasospasm with iron sucrose. 2007 Nephrol. Dial. Transplant. pmid:17327282
Marsillach J et al. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia. 2007 Clin. Exp. Pharmacol. Physiol. pmid:17324148
pmid:17322190
Pai AB et al. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. 2007 Pharmacotherapy pmid:17316146
Breymann C et al. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. 2007 J Perinat Med pmid:17302514
Izuel Rami M et al. [Budget impact analysis of a blood saving program for urgent traumatological surgery]. 2007 Med Clin (Barc) pmid:17266885